medigraphic.com
Colegio de Medicina Interna de México.

2023, Number 1

<< Back Next >>

Med Int Mex 2023; 39 (1)

Multi-facetic tropism of SARS-CoV-2

Del Carpio-Orantes L, Sánchez-Díaz JS, García-Méndez S, Rosas-Lozano AL, Aguilar-Silva A, Mejía-Ramos SG

Language: Spanish
References: 36
Page: 108-113
PDF size: 229.50 Kb.


ABSTRACT

SARS-CoV-2 has a predilection for cell groups that are rich in ACE2 and TMPRSS2 receptors, which are distributed throughout the human body, which means that, in addition to the primary site of contagion or primary infection, which is the respiratory system, the virus tends to spread by different mechanisms, affecting practically all the known organs, apparatuses and systems, with which its tropism becomes extensive, being able to condition diverse pictures together with the respiratory one.


REFERENCES

  1. Tyler KL. Pathogenesis | Animal viruses. Encyclopedia ofVirology 1999; 1175‐1184. doi:10.1006/rwvi.1999.0214.

  2. Del Carpio-Orantes L. Zika, ¿virus neurotrópico? [Zika, aneurotropic virus?]. Rev Med Inst Mex Seguro Soc 2016;54 (4): 540‐543.

  3. Del Carpio-Orantes L. Dengue for apparatus and systems.MEDtube Science 2015; Vol. III (3): 21-24.

  4. Li Yan-Chao, Bai Wan-Zhu, Hashikawa T. The neuroinvasivepotential of SARS-CoV2 May be at least partially responsiblefor the respiratory failure of COVID-19 patients. J Med Virol2020; 1-4. doi: 10.1002/jmv.25728.

  5. Sociedad Española de Neurología. Recomendaciones dela Sociedad Española de Neurología en relación con lapérdida de olfato como posible síntoma precoz de infecciónpor COVID-19. Madrid. Publicado el 21 de marzo de 2020.Consultado en versión electrónica.

  6. Mao L, Wang M, Chen S, He Q, et al. Neurological manifestationsof hospitalized patients with COVID-19 in Wuhan,China: a retrospective case series study. medRxiv 2020.doi: 10.1101/2020.02.22.20026500.

  7. Remes-Troche JM, Ramos-de-la-Medina A, Manríquez-Reyes M, Martínez-Pérez-Maldonado L, Lara EL, Solís-González MA. Initial gastrointestinal manifestations inpatients with SARS-CoV-2 in 112 patients from Veracruz(Southeastern Mexico). Gastroenterology 2020. doi:https://doi.org/10.1053/j.gastro.2020.05.055.

  8. Velarde-Ruiz Velasco JA, García-Jiménez ES, Remes-TrocheJM. Manifestaciones hepáticas y repercusion en el pacientecirrótico de covid-19 [Hepatic manifestations and impactof covid-19 on the cirrhotic patient.] [published onlineahead of print, 2020 May 27]. Rev Gastroenterol Mex 2020.doi:10.1016/j.rgmx.2020.05.002.

  9. Sultan S, Altayar O, Siddique SM, et al. AGA institute rapidreview of the GI and liver manifestations of COVID-19,meta-analysis of international data, and recommendationsfor the consultative management of patients withCOVID-19 [published online ahead of print, 2020 May5]. Gastroenterology 2020; S0016-5085 (20): 30593-X.doi:10.1053/j.gastro.2020.05.001.

  10. Puelles VG, Lütgehetmann M, Lindenmeyer MT, SperhakeJP, et al. Multiorgan and renal tropism of SARSCoV-2 [published online ahead of print, 2020 May13]. N Engl J Med 2020; NEJMc2011400. doi:10.1056/NEJMc2011400.

  11. Su H, Yang M, Wan C, Yi LX, et al. Renal histopathologicalanalysis of 26 postmortem findings of patients withCOVID-19 in China. Kidney Int 2020; 98 (1): 219-227. doi:10.1016/j.kint.2020.04.003.

  12. Centurión OA, Scavenius KE, García LB, Torales JM, MiñoLM. Potential mechanisms of cardiac injury and commonpathways of inflammation in patients with COVID-19[published online ahead of print, 2020 May 27]. CritPathw Cardiol 2020; 10.1097/HPC.0000000000000227.doi:10.1097/HPC.0000000000000227.

  13. Long B, Brady WJ, Koyfman A, Gottlieb M. Cardiovascularcomplications in COVID-19. Am J Emerg Med 2020; S0735-6757 (20): 30277-1. doi:10.1016/j.ajem.2020.04.048.

  14. Recalcati S. Cutaneous manifestations in COVID-19: a firstperspective. J Eur Acad Dermatol Venereol 2020; 34 (5):e212‐e213. doi:10.1111/jdv.16387.

  15. Galván-Casas C, Català A, Carretero-Hernández G,Rodríguez-Jiménez P, et al. Classification of the cutaneousmanifestations of COVID-19: a rapid prospective nationwideconsensus study in Spain with 375 cases. Br J Dermatol2020; 10.1111/bjd.19163. doi:10.1111/bjd.19163.

  16. Sánchez-Velázquez A, Falkenhain D, Rivera-Díaz R. Erythemamultiforme in the context of SARS-Coronavirus-2infection. Med Clin (Barc) 2020; S0025-7753 (20): 30267-0.doi:10.1016/j.medcli.2020.04.016.

  17. Lippi G, Plebani M, Henry BM. Thrombocytopenia is associatedwith severe coronavirus disease 2019 (COVID-19)infections: A meta-analysis. Clin Chim Acta 2020; 506:145‐148. doi:10.1016/j.cca.2020.03.022.

  18. Tan L, Wang Q, Zhang D, et al. Correction: Lymphopeniapredicts disease severity of COVID-19: a descriptive andpredictive study. Signal Transduct Target Ther 2020; 5: 61.doi:10.1038/s41392-020-0159-1.

  19. Wang J, Saguner AM, An J, Ning Y, Yan Y, Li G. Dysfunctionalcoagulation in COVID-19: from cell to bedside. Adv Ther

  20. 2020; 10.1007/s12325-020-01399-7. doi:10.1007/s12325-020-01399-7.20. Bostanci Ceran B, Ozates S. Ocular manifestations of coronavirusdisease 2019. Graefes Arch Clin Exp Ophthalmol2020; 10.1007/s00417-020-04777-7. doi:10.1007/s00417-020-04777-7.

  21. Chen L, Deng C, Chen X, Zhang X, et al. Ocular manifestationsand clinical characteristics of 535 cases of COVID-19in Wuhan, China: a cross-sectional study. Acta Ophthalmol2020; 10.1111/aos.14472. doi:10.1111/aos.14472.

  22. Karimi S, Arabi A, Shahraki T, Safi S. Detection of severeacute respiratory syndrome Coronavirus-2 in the tears ofpatients with Coronavirus disease 2019. Eye (Lond) 2020;1‐4. doi:10.1038/s41433-020-0965-2.

  23. Ryean GA, Purandare NC, McAuliffe FM, Hod M, PurandareCN. Clinical update on COVID-19 in pregnancy: A reviewarticle. J Obstet Gynaecol Res 2020; 10.1111/jog.14321.doi:10.1111/jog.14321.

  24. Chen H, Guo J, Wang C, Luo F, et al. Clinical characteristicsand intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospectivereview of medical records. Lancet 2020; 395 (10226):809‐815. doi:10.1016/S0140-6736(20)30360-3.

  25. Liang H, Acharya G. Novel corona virus disease (COVID-19) in pregnancy: What clinical recommendations tofollow? Acta Obstet Gynecol Scand 2020; 99 (4): 439‐442.doi:10.1111/aogs.13836.

  26. Harahsheh AS, Dahdah N, Newburger JW, Portman MA,Piram M, Tulloh R, et al. Missed or delayed diagnosisof Kawasaki disease during the 2019 novel coronavirusdisease (COVID-19) pandemic. J Pediatr. doi: 10.1016/j.jpeds.2020.04.052.

  27. Verdoni L, Mazza A, Gervasoni A, Martelli L, et al. Anoutbreak of severe Kawasaki-like disease at the Italianepicentre of the SARS-CoV-2 epidemic: an observationalcohort study. Lancet 2020; 10.1016/S0140-6736(20)31103-X. doi:10.1016/S0140-6736(20)31103-X.

  28. Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N,Theocharis P. Hyperinflammatory shock in children duringCOVID-19 pandemic. Lancet 2020; 395 (10237): 1607‐1608.doi:10.1016/S0140-6736(20)31094-1.

  29. Alunno A, Carubbi F, Rodríguez-Carrio J. Storm, typhoon,cyclone or hurricane in patients with COVID-19?Beware of the same storm that has a different origin.RMD Open 2020; 6 (1): e001295. doi:10.1136/rmdopen-2020-001295.

  30. McGonagle D, Sharif K, O’Regan A, Bridgewood C. the roleof cytokines including interleukin-6 in COVID-19 inducedpneumonia and macrophage activation syndrome-like disease.Autoimmun Rev 2020; 19 (6): 102537. doi:10.1016/j.autrev.2020.102537

  31. Speer G, Somogyi P. Thyroid complications of SARS andcoronavirus disease 2019 (COVID-19). Endocr J 2021; 68(2): 129-136. doi: 10.1507/endocrj.EJ20-0443.

  32. Akbas EM, Akbas N. COVID-19, adrenal gland, glucocorticoids,and adrenal insufficiency. Biomed Pap Med FacUniv Palacky Olomouc Czech Repub 2021; 165 (1): 1-7.doi: 10.5507/bp.2021.011.

  33. Alzahrani AS, Mukhtar N, Aljomaiah A, Aljamei H, BakhshA, Alsudani N, Elsayed T, Alrashidi N, Fadel R, AlqahtaniE, Raef H, Butt MI, Sulaiman O. The impact of COVID-19viral infection on the hypothalamic-pituitary-adrenalaxis. Endocr Pract 2021; 27 (2): 83-89. doi: 10.1016/j.eprac.2020.10.014.

  34. Selek A, Güçlü M, Bolu ŞE. COVID-19 pandemic: whatabout the gonads? Hormones 2021; 20 (2): 259-268. doi:10.1007/s42000-021-00277-3.

  35. Abramczyk U, Nowaczyński M, Słomczyński A, WojniczP, Zatyka P, Kuzan A. Consequences of COVID-19 for thepancreas. Int J Mol Sci 2022; 23 (2): 864. doi: 10.3390/ijms23020864.

  36. Del Carpio-Orantes L. Zika and novel coronavirus 2019(2019-nCoV): Pandemic viruses sharing similarities. ArchClin Infect Dis 2020; 15 (3): e103011.




2020     |     www.medigraphic.com